chartexchange

GYRE
Gyre Therapeutics, Inc. Common Stock
stockNASDAQ

Market OpenNov 19, 2026 9:39:49 AM EST
4.70USD+8.180%(+0.36)62,467
3.7300Bid5.4200Ask1.6900Spread

GYRE Financials

In Q3 FY 2026 (ended ), Gyre Therapeutics, Inc. Common Stock (GYRE) reported revenue of $32.93M, net income of −$2.48M, operating cash flow of −$3.98M, and assets of $201.25M (filed ).

Loading financial statements…